○Masazumi Iwashita1, Ryuta Shioi1, Sugiyama Mitsuru1, Hashizume Kohjiro1, Kan Toshiyuki2, Sunagawa Yoichi2, Naito Shiomi2, Takai Hidemichi2, Morimoto Tatsuya2 (1. Biol. Sci. Res., Kao Corporation, 2. Grad. Sch. Pharm. Sci., Shizuoka Univ.)
Session information
Poster Presentation
(B) Pharmaceutical Physics
[27P2-pm2] LC-MS/Spectroscopic analysis/Electrophoresis/Biological analysis
Mon. Mar 27, 2023 3:40 PM - 5:20 PM [Room P2] Gymnasium (1F)
○Hiroyuki Kataoka1, Hayata Ohshima1, Taishi Ohkawa1 (1. School of Pharmacy, Shujitsu University)
○Asuka Honjo1, Hiroyuki Kataoka1 (1. School of Pharmacy, Shujitsu University)
○Mao Honjo1, Hiroyuki Kataoka1 (1. School of Pharmacy, Shujitsu University)
○Atsushi Ishizaki1, Akiko Miura1, Hiroyuki Kataoka1 (1. School of Pharmacy, Shujitsu University)
○Shota Yoshida1,2, Hongyan Zhang1, Ryuji Takahashi1, Sakura Yoshida2, Yumi Abiko2, Akira Toriba2 (1. Kampo Res. Labs., Kracie Pharma, Ltd., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ.)
○Ayane Kobayashi1, Yuki Kitazima1, Mari Ohira1, Suzuna Seko1, Chisato Takahashi1, Moeko Itoga2, Asuka Naraoka2, Hiroshi Naka2, Keiko Maekawa1 (1. Doshisha women's college of liberal arts, 2. Grad. Sch. Pharm. Sci., Kyoto University.)
○Yusuke Jikumaru1, Hirokazu Sawada1 (1. Agilent Technologies Japan, Ltd)
○Satoshi Kagami1, Takeshi Otsuka1, Yuka Ito1, Sadao Nakamura1 (1. Agilent Technologies Japan, Ltd)
○Manami Hori1, Chisato Takahasi1, Mohammad Sofiqur Rahman2, Feiyu Zhu2, Shu Zhu2, Naoko Yoshida2,3, Kazuko Kimura2,3, Keiko Maekawa1 (1. Doshisha women's college of liberal arts, 2. Grad. Sch. Med. Sci., Kanazawa Univ., 3. Medicines Security Workshop)
○Katsumi Matsumoto1, Masayuki Baba1, Takahiro Sasaki1, Kazuyoshi Yokota1 (1. Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.)
○Youji Fujita1, Mayumi Abe1 (1. TOSOH Analysis and Research Center Co.,Ltd.)
○Chihiro Miyazato1, Itsuki Nakatake1, Shimba Kawasue 1, Reiko Koga1, Takeyuki Akita2, Kenji Hamase2, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. Pharm. Sci., Kyusyu Univ.)
○Nao Ando1, Shimba Kawasue1, Yushun Tajiri1, Reiko Koga1, Hideyuki Yoshida1, Hitoshi Nohta1 (1. Fac. Pharm. Sci., Fukuoka Univ. )
○Sayaka Kuzunotani1, Tsukasa Tatsumi(Tanaka)2, Yukihiro Kuroda1,2 (1. Grad.Sch.Pharm.Sci.,Mukogawa Women's Univ., 2. Sch.Pharm.Sci.,Mukogawa Women's Univ.)
○Hashii Noritaka1, Yoshiko Tousaka1, Masashi Hyuga1, Akiko Watabe Ishii1 (1. Natl. Inst. Health Sci.)
○Yuka Mizumoto1, Ayaka Hirakawa2, Shoichi Kusunose1, Yuki Sugiura3, Koshiro Nishimoto4, Tatsuya Higashi1 (1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2. Graduate School of Pharmaceutical Sciences, Tokyo University of Science, 3. Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, 4. International Medical Center, Saitama Medical University)
○Shota Nakamura1, Tatsuya Ezaki1, Yun W. Alelyunas2, Mark D. Wrona2, Ying Qing Yu2, Dominic Levasseur2, Ann Gray2, Suraj Dhungana2 (1. Nihon Waters, 2. Waters Technologies)
○Shuhei Yamagata1, Hitomi Matsumoto1, Shinnya Sakuma1, Yoshinori Kato1, Yusuke Iwasaki1 (1. Hoshi University)
○Shunsuke Hoshina1, Daisuke Takakura1, Nana Kawasaki1 (1. Grad. Sch. of Medical Life Sci., Yokohama City Univ.)
○Yasunori Hamazaki1,2, Satoko Shimbara-Matsubayashi1, Koji Karasawa1, Nanami Fukui2, Keiichi Honma2, Yoshijiro Nakajima2, Masaru Kato1 (1. Grad. Sch. Pharm. Sci., Showa Univ., 2. OHTA'S ISAN Co., Ltd.)
○Takashi Misawa1, Genichiro Tsuji1, Yosuke Demizu1 (1. National Institute of health sciences)
○Kotaro Endo1, Hiroshi Hisada2, Koki Otaka3, Yukiya Ymaguchi1, Toshiro Fukami3 (1. Sannova.co.,Ltd., 2. Tekanalysis Inc., 3. Meiji Pharmaceutical University)
○Koichiro Akiyama1, Kazuki Horita1, Kazuhiro Takahashi1, Hiroshi Satozono1, Tomoaki Sakamoto2 (1. HAMAMATSU PHOTONICS K.K., 2. National Institute of Health Sciences)
Michinari Sakai1, Mari Uehara1, Tomomi Ikeda1, Hiroki Sagawa1, Hisato Kato2, Kazufumi Masuda2, ○Junichi Odo1,2 (1. Fac. Sci., Okayama Univ. Sci., 2. Sch. Pharm., Shujitsu Univ.)
○Yasuto Fujimaki1, Toshiyuki Chikuma2, Tomoaki Sakamoto2,3 (1. Tokyo Metropolitan Industrial Technology Research Institute, 2. National Institute of Health Sciences, 3. Research Institute of Electronics, Shizuoka University)
○Minako Okamoto1, Hiroyuki Yasui1 (1. Kyoto Pharm.Univ.)
[27P2-pm2-028S] A new boron-rhodamine derivative containing carboxylic acid (BRhoC) as a chemosensor
○Toranosuke Sato1, Honoka Okawara1, Yuta Komori1, Shun Sugimoto1, Ryo Watanabe1, Yuki Takano1, Satoshi Kitaoka1, Yuya Egawa1 (1. Pharm. Josai Univ.)
○Yutaka SADAKANE1, Yasuhiro Kubota1, Isao Otsuka2 (1. Dep. Pharm. Sci., Suzuka Univ. Med. Sci., 2. Dep. Pharm. Sci., Kyushu Univ. Health. Sci.)
○Mitsuki Kasai1, Yuka Ito1, Chihiro Hirai1, Shota Morimoto1, Yutaka Sadakane1 (1. Dep.pharm.Sci.,Suzuka Univ.Med.Sci.)
○Yukihiro Esaka1,2, Daiki Maeda1, Soo Takasu1, Takuhei Yamamoto1,2, Taro Udagawa3, Yoshinari Sawama4 (1. Gifu Pharm. Univ., 2. United Grad. Sch. Drug Discov. Med. Info. Sci., Gifu Univ., 3. Facul. Eng., Gifu Univ., 4. Grad. Sch. Pharm., Osaka Univ.)
○Yuki Kiguchi1, Izumi Morita1, Akari Tsuruno1, Norihiro Kobayashi1 (1. Kobe Pharm. Univ.)
[27P2-pm2-033] Development of immunoassay system for quantification of urinary globotriaosylceramide
○Maina Koizumi1, Takahiro Tsukimura1, Tomoki Isshiki1, Maika Ogura1, Miwa Matsuzu1, Hitoshi Sakuraba1, Tadayasu Togawa1 (1. Meiji Pharmaceutical Univ.)
○Hiroyuki Oyama1, Izumi Morita1, Norihiro Kobayashi1 (1. Kobe Pharm Univ)
○Izumi Morita1, Yuki Kiguchi1, Haruna Kubo1, Momo Ishida1, Hiroyuki Oyama1, Norihiro Kobayashi1 (1. Kobe Pharm. Univ.)
○Yuta Kyosei1, Sou Yamura1, Mayuri Namba1, Teruki Yoshimura2, Etsuro Ito3 (1. Department of Biology, Waseda University, 2. School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 3. Depatment of Biology, Waseda University )